Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study
CONCLUSIONS: RSVpreF vaccine and Nirsevimab may be cost-effective in Vietnam if appropriately priced.PMID:37690873 | DOI:10.1016/j.vaccine.2023.09.003
Source: Vaccine - Category: Allergy & Immunology Authors: Lien Anh Ha Do Nguyen Thanh Nhan Le Sarwat Mahmud Kim Mulholland Clint Pecenka Andrew Clark Source Type: research
More News: Allergy & Immunology | AstraZeneca | Children | Disability | Pfizer | Respiratory Medicine | Study | Vaccines | Vietnam Health